← Open Payments lookup

ALLISON WADE: Open Payments

NPI 1356518872 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,352 in 57 payments from 12 companies in 2025. Trend: 2023 $907 · 2024 $835 · 2025 $1,352

Food & beverage: $1,352
CompanyPaymentsAmount
Novo Nordisk Inc13$447
ABBVIE INC.22$421
AstraZeneca Pharmaceuticals LP7$171
Lundbeck LLC3$85
PFIZER INC.3$56
Amgen Inc.2$41
Phathom Pharmaceuticals, Inc.2$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Abbott Laboratories1$22
Boehringer Ingelheim Pharmaceuticals, Inc.1$21

Products named: Ozempic, QULIPTA, VRAYLAR, AIRSUPRA, VYEPTI, UBRELVY, Rybelsus, NURTEC ODT.

Industry payments across MD — which companies pay providers there.